According to FibroGen's latest financial reports the company's current revenue (TTM ) is C$41.66 Million. a decrease over the revenue in the year 2023 that were of C$0.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | C$42.5 M | -78.31% |
2023 | C$0.19 B | 2.62% |
2022 | C$0.19 B | -36.32% |
2021 | C$0.29 B | 33.39% |
2020 | C$0.22 B | -32.91% |
2019 | C$0.33 B | 15.52% |
2018 | C$0.29 B | 61.62% |
2017 | C$0.17 B | -25.62% |
2016 | C$0.24 B | -3.8% |
2015 | C$0.25 B | 57.09% |
2014 | C$0.15 B |